Dose-dependent inhibition of KIT autophosphorylation in response to either single or repeated treatment with M4205 was confirmed in other GIST in vivo tumor models bearing different activating and resistance mutations of KIT (Supplementary Fig. S4B–S4D). The gene discussed is KIT; the disease is neoplasm.